Related Experiment Videos
Granulocyte transfusion therapy
1Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Harper Hospital, Detroit, MI 48201, USA.
Current Opinion in Hematology
|January 23, 1999
Summary
Granulocyte colony-stimulating factor (G-CSF) boosts granulocyte yields, enhancing transfusion effectiveness for infections in patients with low white blood cell counts. Higher doses improve post-transfusion cell counts for extended periods.
Area of Science:
- Hematology
- Infectious Diseases
- Transfusion Medicine
Background:
- Granulocyte transfusions historically treat infections in granulocytopenic patients.
- Challenges include donor granulocyte yield and recipient alloimmunization.
- Granulocyte colony-stimulating factor (G-CSF) has renewed interest in this therapy.
Purpose of the Study:
- To evaluate the efficacy of G-CSF stimulated granulocyte transfusions.
- To assess the impact of higher granulocyte doses on patient outcomes.
- To explore the utility of G-CSF in treating invasive fungal infections.
Main Methods:
- Utilizing G-CSF to stimulate granulocytosis in donors.
- Collecting and transfusing higher doses of granulocytes.
- Monitoring post-transfusion granulocyte increments and clinical outcomes.
Main Results:
- G-CSF stimulation routinely increases granulocyte yields 3-4 fold.
- Post-transfusion granulocyte levels are sustained for over 24 hours.
- Improved yields address historical limitations in granulocyte collection.
Conclusions:
- G-CSF significantly enhances granulocyte collection for transfusion.
- Higher dose granulocyte transfusions show promise for managing refractory infections.
- Further studies are needed to define the clinical utility in specific patient populations.